{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:12:08Z","timestamp":1767917528134,"version":"3.49.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["F-365"],"award-info":[{"award-number":["F-365"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271 - TRR 205"],"award-info":[{"award-number":["314061271 - TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AL 203\/11-1"],"award-info":[{"award-number":["AL 203\/11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.lpm.2022.104114","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T02:28:38Z","timestamp":1643941718000},"page":"104114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adrenal functional imaging"],"prefix":"10.1016","volume":"51","author":[{"given":"Rudolf A.","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schirbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-8986","authenticated-orcid":false,"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lpm.2022.104114_bib0001","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0002","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: european society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41181-021-00123-2","article-title":"Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals","volume":"6","author":"Gillings","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00268-011-1374-2","article-title":"Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors","volume":"36","author":"Gust","year":"2012","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0005","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2005-1540","article-title":"Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography","volume":"91","author":"Leboulleux","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.lpm.2022.104114_bib0006","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00259-014-2834-3","article-title":"Impact of (1)(8)F-FDG PET\/CT on the management of adrenocortical carcinoma: analysis of 106 patients","volume":"41","author":"Takeuchi","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0007","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/RLU.0000000000001435","article-title":"Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients","volume":"42","author":"Bluemel","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0008","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1210\/jc.2008-0050","article-title":"[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes","volume":"93","author":"Hahner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0009","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2011-2765","article-title":"[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma","volume":"97","author":"Hahner","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2022.104114_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-021-05477-y","article-title":"Novel CYP11B-ligand [123\/131I]IMAZA as promising theranostic tool for adrenocortical tumors comprehensive preclinical characterization and first clinical experience","author":"Heinze","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0011","first-page":"1","article-title":"NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\"incidentaloma\")","volume":"19","year":"2002","journal-title":"NIH Consens State Sci Statements"},{"issue":"16","key":"10.1016\/j.lpm.2022.104114_bib0012","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMcp2031112","article-title":"Adrenal incidentaloma","volume":"384","author":"Kebebew","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0013","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal Incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.lpm.2022.104114_bib0014","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrclinonc.2012.188","article-title":"Is there still a role for SPECT-CT in oncology in the PET-CT era?","volume":"9","author":"Hicks","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.lpm.2022.104114_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1524\/ract.92.4.297.35598","article-title":"[123\/131I]Iodometomidate as a radioligand for functional diagnosis of adrenal disease: synthesis, structural requirements and biodistribution","author":"Schirbel","year":"2004","journal-title":"Radiochim Acta"},{"issue":"7","key":"10.1016\/j.lpm.2022.104114_bib0016","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1021\/jm800012w","article-title":"New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues","volume":"51","author":"Zolle","year":"2008","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.lpm.2022.104114_bib0017","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2012-3045","article-title":"Functional characterization of adrenal lesions using [123I]IMTO-SPECT\/CT","volume":"98","author":"Hahner","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11100569","article-title":"Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance","volume":"259","author":"Boland","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.lpm.2022.104114_bib0019","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/jc.2008-2302","article-title":"18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients","volume":"94","author":"Groussin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0020","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-20-1459","article-title":"Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation","volume":"185","author":"Ishiwata","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0022","first-page":"166","article-title":"(18)F-FDG PET\/CT in bilateral primary adrenal T-cell lymphoma","volume":"14","author":"Santhosh","year":"2011","journal-title":"Hell J Nucl Med"},{"issue":"4","key":"10.1016\/j.lpm.2022.104114_bib0023","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.rlu.0000155983.46815.1c","article-title":"FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature","volume":"30","author":"Kumar","year":"2005","journal-title":"Clin Nucl Med"},{"issue":"12","key":"10.1016\/j.lpm.2022.104114_bib0024","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.lpm.2022.104114_bib0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/RLU.0b013e318262af6b","article-title":"Adrenal epithelioid angiosarcoma metastatic to the epicardium: diagnosis by 18F-FDG PET\/CT","volume":"37","author":"Derlin","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0026","first-page":"469","article-title":"The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland","volume":"29","author":"Van Laarhoven","year":"2009","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.lpm.2022.104114_bib0027","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF00185607","article-title":"Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis","volume":"71","author":"Weber","year":"1993","journal-title":"Clin Investig"},{"issue":"Suppl 3","key":"10.1016\/j.lpm.2022.104114_bib0028","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2362.2000.0300s3076.x","article-title":"New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line","volume":"30","author":"Fassnacht","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0029","first-page":"982","article-title":"In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors","volume":"39","author":"Bergstrom","year":"1998","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0030","first-page":"275","article-title":"PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate","volume":"41","author":"Bergstrom","year":"2000","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.37894","article-title":"(18)F-Labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging","volume":"10","author":"Werner","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0032","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00259-005-0062-6","article-title":"[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers","volume":"33","author":"Wadsak","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.lpm.2022.104114_bib0033","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-003-1252-8","article-title":"In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats","volume":"30","author":"Mitterhauser","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.lpm.2022.104114_bib0034","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nucmedbio.2018.11.002","article-title":"Development of [(18)F]FAMTO: a novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands","volume":"68-69","author":"Bongarzone","year":"2019","journal-title":"Nucl Med Biol"},{"issue":"10","key":"10.1016\/j.lpm.2022.104114_bib0035","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.7150\/ijms.51206","article-title":"Para-chloro-2-[(18)F]fluoroethyl-etomidate: a promising new PET radiotracer for adrenocortical imaging","volume":"18","author":"Silins","year":"2021","journal-title":"Int J Med Sci"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0036","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2967\/jnmt.109.062950","article-title":"Practical aspects of 18F-FDG PET when receiving 18F-FDG from a distant supplier","volume":"37","author":"Ducharme","year":"2009","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0037","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2022.104114_bib0038","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.lpm.2022.104114_bib0039","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0041","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archinte.1972.00320030037002","article-title":"Primary aldosteronism. Photoscanning of tumors after administration of 131 I-19-iodocholesterol","volume":"129","author":"Conn","year":"1972","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0042","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem-45-2-353","article-title":"A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans","volume":"45","author":"Sarkar","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0043","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1470013","article-title":"Functional scintigraphy of the adrenal gland","volume":"147","author":"Rubello","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.lpm.2022.104114_bib0044","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","article-title":"131I-6beta-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results","volume":"50","author":"Yen","year":"2009","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.lpm.2022.104114_bib0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/jc.2005-2273","article-title":"[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings","volume":"91","author":"Hennings","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0046","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0047","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-20-0532","article-title":"Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism","volume":"183","author":"Soinio","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0048","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A Novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2022.104114_bib0049","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2022.104114_bib0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-10-1085","article-title":"Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands","volume":"164","author":"Wang","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2022.104114_bib0051","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04529018, last assessed June, 30, 2021."},{"issue":"11","key":"10.1016\/j.lpm.2022.104114_bib0052","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2022.104114_bib0053","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.nucmedbio.2008.04.007","article-title":"A clinical overview of pheochromocytomas\/paragangliomas and carcinoid tumors","volume":"35","author":"Ilias","year":"2008","journal-title":"Nucl Med Biol"},{"issue":"4","key":"10.1016\/j.lpm.2022.104114_bib0054","first-page":"358","article-title":"Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication","volume":"22","author":"Wieland","year":"1981","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.lpm.2022.104114_bib0055","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","article-title":"Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial","volume":"50","author":"Wiseman","year":"2009","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.lpm.2022.104114_bib0056","first-page":"1138","article-title":"The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma","volume":"35","author":"Mozley","year":"1994","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0057","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0039-6060(03)00416-1","article-title":"Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?","volume":"134","author":"Miskulin","year":"2003","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.lpm.2022.104114_bib0058","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.118.217463","article-title":"Efficacy and safety of high-specific-activity (131)I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma","volume":"60","author":"Pryma","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0059","first-page":"1","article-title":"Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma","volume":"36","author":"Tenenbaum","year":"1995","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jcem.86.2.7194","article-title":"Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors","volume":"86","author":"Kaltsas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0061","first-page":"1125","article-title":"PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma","volume":"33","author":"Shulkin","year":"1992","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0062","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","article-title":"18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"28","author":"Hoegerle","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.lpm.2022.104114_bib0063","article-title":"Personalized management of pheochromocytoma and paraganglioma","author":"Nolting","year":"2021","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0064","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"(68)Ga-DOTATATE and (18)F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"issue":"7","key":"10.1016\/j.lpm.2022.104114_bib0065","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/cancers11070909","article-title":"Favorable outcome in patients with pheochromocytoma and paraganglioma treated with (177)Lu-DOTATATE","volume":"11","author":"Vyakaranam","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.lpm.2022.104114_bib0066","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1742-1241.2006.01220.x","article-title":"Analysis of adrenal masses by 18F-FDG positron emission tomography scanning","volume":"61","author":"Han","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0067","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1500789","article-title":"18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients","volume":"150","author":"Tenenbaum","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0068","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.106.035774","article-title":"Partial-volume effect in PET tumor imaging","volume":"48","author":"Soret","year":"2007","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.lpm.2022.104114_bib0069","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2005-2612","article-title":"Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma","volume":"91","author":"Mackie","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/EJE-15-0707","article-title":"18F-FDG PET\/CT in the post-operative monitoring of patients with adrenocortical carcinoma","volume":"173","author":"Ardito","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0071","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-002-1025-9","article-title":"11C-metomidate PET imaging of adrenocortical cancer","volume":"30","author":"Khan","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.lpm.2022.104114_bib0072","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12149-018-1290-8","article-title":"CXCR4-directed theranostics in oncology and inflammation","volume":"32","author":"Kircher","year":"2018","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.lpm.2022.104114_bib0073","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lpm.2022.104114_bib0074","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fonc.2019.00770","article-title":"CXCR4-directed imaging in solid tumors","volume":"9","author":"Werner","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.lpm.2022.104114_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597878","article-title":"Impact of the chemokine receptors CXCR4 and CXCR7 on clinical outcome in adrenocortical carcinoma","volume":"11","author":"Chifu","year":"2020","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2022.104114_bib0076","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2967\/jnumed.115.167361","article-title":"First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu- and 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease","volume":"57","author":"Herrmann","year":"2016","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.lpm.2022.104114_bib0077","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2967\/jnumed.118.223420","article-title":"Side effects of CXC-chemokine receptor 4-directed endoradiotherapy with pentixather before hematopoietic stem cell transplantation","volume":"60","author":"Maurer","year":"2019","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.lpm.2022.104114_bib0078","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1210\/clinem\/dgz091","article-title":"Treatment with 90Y\/177Lu-DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors","volume":"105","author":"Grisanti","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2022.104114_bib0079","doi-asserted-by":"crossref","DOI":"10.1210\/js.2019-SUN-335","article-title":"The chemokine receptor 4 (CXCR4) plays an important role in adrenocortical carcinoma cell proliferation","volume":"3","author":"Kitawaki","year":"2019","journal-title":"J Endocr Soc"},{"issue":"37","key":"10.1016\/j.lpm.2022.104114_bib0080","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","article-title":"Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4","volume":"41","author":"Hess","year":"2020","journal-title":"Eur Heart J"},{"issue":"385(12)","key":"10.1016\/j.lpm.2022.104114_bib0081","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"16","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2022.104114_bib0082","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fendo.2019.00226","article-title":"Diagnostic role of prostate-specific membrane antigen in adrenocortical carcinoma","volume":"10","author":"Gu","year":"2019","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2022.104114_bib0083","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/RLU.0000000000002064","article-title":"Prostate-specific membrane antigen expression in adrenocortical carcinoma on 68ga-prostate-specific membrane antigen PET\/CT","volume":"43","author":"Arora","year":"2018","journal-title":"Clin Nucl Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498222000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498222000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:59Z","timestamp":1760105279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498222000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0755498222000070"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2022.104114","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal functional imaging","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2022.104114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104114"}}